{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T07:07:50Z","timestamp":1788937670179,"version":"build-2803163510"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Thailand Science Research and Innovation Fund Chulalongkorn University","award":["HEA663300009"],"award-info":[{"award-number":["HEA663300009"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacol. Rep"],"DOI":"10.1007\/s43440-026-00895-x","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T07:01:52Z","timestamp":1788937312000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Unveiling novel transcriptomic prognostic biomarkers for specific breast cancer subtypes and treatment regimens"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-6783-8547","authenticated-orcid":false,"given":"Krittin","family":"Pitinanon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chotiphuk","family":"Kusalasaiyanon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8219-1489","authenticated-orcid":false,"given":"Wathunya","family":"Hawhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4814-8616","authenticated-orcid":false,"given":"Yu-Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4299-873X","authenticated-orcid":false,"given":"Pasrawin","family":"Taechawattananant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3622-532X","authenticated-orcid":false,"given":"Varalee","family":"Yodsurang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,9]]},"reference":[{"issue":"3","key":"895_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"issue":"10087","key":"895_CR2","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1016\/S0140-6736(16)32454-0","volume":"389","author":"C Denkert","year":"2017","unstructured":"Denkert C, Liedtke C, Tutt A, von Minckwitz G. Molecular alterations in triple-negative breast cancer\u2014the road to new treatment strategies. Lancet. 2017;389(10087):2430\u201342. https:\/\/doi.org\/10.1016\/S0140-6736(16)32454-0.","journal-title":"Lancet"},{"key":"895_CR3","unstructured":"National Comprehensive Cancer Network (NCCN). Breast cancer (Version 6.2024). Plymouth Meeting (PA): NCCN; 2024 [cited 2024 Nov 22]. Available from: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/breast.pdf."},{"issue":"19","key":"895_CR4","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1056\/NEJMoa1701830","volume":"377","author":"H Pan","year":"2017","unstructured":"Pan H, Gray R, Braybrooke J, Davies C, Taylor C, McGale P, et al. 20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years. N Engl J Med. 2017;377(19):1836\u201346. https:\/\/doi.org\/10.1056\/NEJMoa1701830.","journal-title":"N Engl J Med"},{"issue":"24","key":"895_CR5","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1200\/jco.2015.61.1459","volume":"33","author":"C Van Poznak","year":"2015","unstructured":"Van Poznak C, Somerfield MR, Bast RC, Cristofanilli M, Goetz MP, Gonzalez-Angulo AM, et al. Use of Biomarkers to Guide Decisions on Systemic Therapy for Women with Metastatic Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2015;33(24):2695\u2013704. https:\/\/doi.org\/10.1200\/jco.2015.61.1459.","journal-title":"J Clin Oncol"},{"key":"895_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fonc.2022.1038835","volume":"12","author":"W Sakares","year":"2022","unstructured":"Sakares W, Wongkhattiya W, Vichayachaipat P, Chaiwut C, Yodsurang V, Nutthachote P. Accuracy of CCL20 expression level as a liquid biopsy-based diagnostic biomarker for ovarian carcinoma. Front Oncol. 2022;12:1\u201312. https:\/\/doi.org\/10.3389\/fonc.2022.1038835.","journal-title":"Front Oncol"},{"issue":"27","key":"895_CR7","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1056\/NEJMoa041588","volume":"351","author":"S Paik","year":"2004","unstructured":"Paik S, Shak S, Tang G, Kim C, Baker J, Cronin M, et al. A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer. N Engl J Med. 2004;351(27):2817\u201326. https:\/\/doi.org\/10.1056\/NEJMoa041588.","journal-title":"N Engl J Med"},{"issue":"2","key":"895_CR8","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa1804710","volume":"379","author":"JA Sparano","year":"2018","unstructured":"Sparano JA, Gray RJ, Makower DF, Pritchard KI, Albain KS, Hayes DF, et al. Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer. N Engl J Med. 2018;379(2):111\u201321. https:\/\/doi.org\/10.1056\/NEJMoa1804710.","journal-title":"N Engl J Med"},{"issue":"10087","key":"895_CR9","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1016\/s01406736(16)32419-9","volume":"389","author":"NC Turner","year":"2017","unstructured":"Turner NC, Neven P, Loibl S, Andre F. Advances in the treatment of advanced oestrogen-receptor-positive breast cancer. Lancet. 2017;389(10087):2403\u201314. https:\/\/doi.org\/10.1016\/s01406736(16)32419-9.","journal-title":"Lancet"},{"issue":"32","key":"895_CR10","doi-asserted-by":"publisher","first-page":"3638","DOI":"10.1200\/jco.2017.75.6155","volume":"35","author":"MP Goetz","year":"2017","unstructured":"Goetz MP, Toi M, Campone M, Sohn J, Paluch-Shimon S, Huober J, et al. MONARCH 3: Abemaciclib as Initial Therapy for Advanced Breast Cancer. J Clin Oncol. 2017;35(32):3638\u201346. https:\/\/doi.org\/10.1200\/jco.2017.75.6155.","journal-title":"J Clin Oncol"},{"issue":"7221","key":"895_CR11","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/nature07509","volume":"456","author":"ET Wang","year":"2008","unstructured":"Wang ET, Sandberg R, Luo S, Khrebtukova I, Zhang L, Mayr C, et al. Alternative isoform regulation in human tissue transcriptomes. Nature. 2008;456(7221):470\u20136. https:\/\/doi.org\/10.1038\/nature07509.","journal-title":"Nature"},{"issue":"1a","key":"895_CR12","doi-asserted-by":"publisher","first-page":"A68","DOI":"10.5114\/wo.2014.47136","volume":"19","author":"K Tomczak","year":"2015","unstructured":"Tomczak K, Czerwi\u0144ska P, Wiznerowicz M. The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge. Contemp Oncol (Pozn). 2015;19(1a):A68\u201377. https:\/\/doi.org\/10.5114\/wo.2014.47136.","journal-title":"Contemp Oncol (Pozn)"},{"issue":"1","key":"895_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms11479","volume":"7","author":"B Pereira","year":"2016","unstructured":"Pereira B, Chin S-F, Rueda OM, Vollan H-KM, Provenzano E, Bardwell HA, et al. The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes. Nat Commun. 2016;7(1):1\u201315. https:\/\/doi.org\/10.1038\/ncomms11479.","journal-title":"Nat Commun"},{"issue":"1","key":"895_CR14","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2009","unstructured":"Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2009;26(1):139\u201340. https:\/\/doi.org\/10.1093\/bioinformatics\/btp616.","journal-title":"Bioinformatics"},{"issue":"1","key":"895_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2105-11-367","volume":"11","author":"R Gaujoux","year":"2010","unstructured":"Gaujoux R, Seoighe C. A flexible R package for nonnegative matrix factorization. BMC Bioinformatics. 2010;11(1):1\u20139. https:\/\/doi.org\/10.1186\/1471-2105-11-367.","journal-title":"BMC Bioinformatics"},{"issue":"12","key":"895_CR16","doi-asserted-by":"publisher","first-page":"4164","DOI":"10.1073\/pnas.0308531101","volume":"101","author":"J-P Brunet","year":"2004","unstructured":"Brunet J-P, Tamayo P, Golub TR, Mesirov JP. Metagenes and molecular pattern discovery using matrix factorization. Proc Natl Acad Sci U S A. 2004;101(12):4164\u20139. https:\/\/doi.org\/10.1073\/pnas.0308531101.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"895_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.prp.2023.154347","volume":"242","author":"A Boccarelli","year":"2023","unstructured":"Boccarelli A, Del Buono N, Esposito F. Cluster of resistance-inducing genes in MCF-7 cells by estrogen, insulin, methotrexate and tamoxifen extracted via NMF. Pathol Res Pract. 2023;242:1\u201313. https:\/\/doi.org\/10.1016\/j.prp.2023.154347.","journal-title":"Pathol Res Pract"},{"issue":"12","key":"895_CR18","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1093\/bioinformatics\/btm134","volume":"23","author":"H Kim","year":"2007","unstructured":"Kim H, Park H. Sparse non-negative matrix factorizations via alternating non-negativity-constrained least squares for microarray data analysis. Bioinformatics. 2007;23(12):1495\u2013502. https:\/\/doi.org\/10.1093\/bioinformatics\/btm134.","journal-title":"Bioinformatics"},{"key":"895_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1177932220906827","volume":"14","author":"F Esposito","year":"2020","unstructured":"Esposito F, Boccarelli A, Del Buono N. An NMF-Based Methodology for Selecting Biomarkers in the Landscape of Genes of Heterogeneous Cancer-Associated Fibroblast Populations. Bioinform Biol Insights. 2020;14:1\u201313. https:\/\/doi.org\/10.1177\/1177932220906827.","journal-title":"Bioinform Biol Insights"},{"issue":"W1","key":"895_CR20","doi-asserted-by":"publisher","first-page":"W216","DOI":"10.1093\/nar\/gkac194","volume":"50","author":"BT Sherman","year":"2022","unstructured":"Sherman BT, Hao M, Qiu J, Jiao X, Baseler MW, Lane HC, et al. DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update). Nucleic Acids Res. 2022;50(W1):W216\u201321. https:\/\/doi.org\/10.1093\/nar\/gkac194.","journal-title":"Nucleic Acids Res"},{"key":"895_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21769\/BioProtoc.3429","volume":"9","author":"T Bonnot","year":"2019","unstructured":"Bonnot T, Gillard MB, Nagel DH. A simple protocol for informative visualization of enriched gene ontology terms. Bio Protoc. 2019;9:1\u20139.","journal-title":"Bio Protoc"},{"issue":"3","key":"895_CR22","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1080\/07853890701214881","volume":"39","author":"P May","year":"2007","unstructured":"May P, Woldt E, Matz RL, Boucher P. The LDL receptor-related protein (LRP) family: An old family of proteins with new physiological functions. Ann Med. 2007;39(3):219\u201328. https:\/\/doi.org\/10.1080\/07853890701214881.","journal-title":"Ann Med"},{"issue":"2","key":"895_CR23","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s00109-018-01732-2","volume":"97","author":"Y Asano","year":"2019","unstructured":"Asano Y, Takeuchi T, Okubo H, Saigo C, Kito Y, Iwata Y, et al. Nuclear localization of LDL receptor-related protein 1B in mammary gland carcinogenesis. J Mol Med. 2019;97(2):257\u201368. https:\/\/doi.org\/10.1007\/s00109-018-01732-2.","journal-title":"J Mol Med"},{"issue":"9","key":"895_CR24","doi-asserted-by":"publisher","first-page":"3421","DOI":"10.1172\/JCI94233","volume":"127","author":"W Li","year":"2017","unstructured":"Li W, Zhang Z, Liu X, Cheng X, Zhang Y, Han X, et al. The FOXN3-NEAT1-SIN3A repressor complex promotes progression of hormonally responsive breast cancer. J Clin Invest. 2017;127(9):3421\u201340. https:\/\/doi.org\/10.1172\/JCI94233.","journal-title":"J Clin Invest"},{"issue":"1","key":"895_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1476-511X-13-16","volume":"13","author":"C Rodrigues dos Santos","year":"2014","unstructured":"Rodrigues dos Santos C, Domingues G, Matias I, Matos J, Fonseca I, de Almeida JM, et al. LDL-cholesterol signaling induces breast cancer proliferation and invasion. Lipids Health Dis. 2014;13(1):1\u20139. https:\/\/doi.org\/10.1186\/1476-511X-13-16.","journal-title":"Lipids Health Dis"},{"issue":"2","key":"895_CR26","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3892\/or.2011.1284","volume":"26","author":"CG Torres","year":"2011","unstructured":"Torres CG, Ram\u00edrez ME, Cruz P, Epu\u00f1an MJ, Valladares LE, Sierralta WD. 27-hydroxycholesterol induces the transition of MCF7 cells into a mesenchymal phenotype. Oncol Rep. 2011;26(2):389\u201397. https:\/\/doi.org\/10.3892\/or.2011.1284.","journal-title":"Oncol Rep"},{"issue":"29","key":"895_CR27","doi-asserted-by":"publisher","first-page":"6837","DOI":"10.1523\/jneurosci.3532-16.2017","volume":"37","author":"E Jung","year":"2017","unstructured":"Jung E, Osswald M, Blaes J, Wiestler B, Sahm F, Schmenger T, et al. Tweety-Homolog 1 Drives Brain Colonization of Gliomas. J Neurosci. 2017;37(29):6837\u201350. https:\/\/doi.org\/10.1523\/jneurosci.3532-16.2017.","journal-title":"J Neurosci"},{"key":"895_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fonc.2022.945896","volume":"12","author":"J Zhao","year":"2022","unstructured":"Zhao J, Li M, Xu J, Cheng W. The modulation of ion channels in cancer chemo-resistance. Front Oncol. 2022;12:1\u201315. https:\/\/doi.org\/10.3389\/fonc.2022.945896.","journal-title":"Front Oncol"},{"issue":"1","key":"895_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1476-4598-12-106","volume":"12","author":"J-H Ko","year":"2013","unstructured":"Ko J-H, Ko EA, Gu W, Lim I, Bang H, Zhou T. Expression profiling of ion channel genes predicts clinical outcome in breast cancer. Mol Cancer. 2013;12(1):1\u201317. https:\/\/doi.org\/10.1186\/1476-4598-12-106.","journal-title":"Mol Cancer"},{"issue":"6","key":"895_CR30","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.bbamcr.2016.10.017","volume":"1864","author":"C Enrich","year":"2017","unstructured":"Enrich C, Rentero C, Grewal T. Annexin A6 in the liver: From the endocytic compartment to cellular physiology. Biochim Biophys Acta Mol Cell Res. 2017;1864(6):933\u201346. https:\/\/doi.org\/10.1016\/j.bbamcr.2016.10.017.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"issue":"17","key":"895_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms20174197","volume":"20","author":"M Okano","year":"2019","unstructured":"Okano M, Oshi M, Butash AL, Katsuta E, Tachibana K, Saito K, et al. Triple-Negative Breast Cancer with High Levels of Annexin A1 Expression Is Associated with Mast Cell Infiltration, Inflammation, and Angiogenesis. Int J Mol Sci. 2019;20(17):1\u201311. https:\/\/doi.org\/10.3390\/ijms20174197.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"895_CR32","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1056\/NEJMoa1913948","volume":"384","author":"L Dorling","year":"2021","unstructured":"Dorling L, Carvalho S, Allen J, Gonz\u00e1lez-Neira A, Luccarini C, Wahlstr\u00f6m C, et al. Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women. N Engl J Med. 2021;384(5):428\u201339. https:\/\/doi.org\/10.1056\/NEJMoa1913948.","journal-title":"N Engl J Med"},{"key":"895_CR33","volume-title":"Pathophysiology of Disease: An Introduction to Clinical Medicine","year":"2019","unstructured":"Hammer GD, McPhee SJ, editors. Pathophysiology of Disease: An Introduction to Clinical Medicine. 8th ed. New York, NY: McGraw-Hill Education; 2019.","edition":"8"},{"issue":"10","key":"895_CR34","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1089\/thy.1998.8.897","volume":"8","author":"JF Wilber","year":"1998","unstructured":"Wilber JF, XU AH. The Thyrotropin-Releasing Hormone Gene 1998: Cloning, Characterization, and Transcriptional Regulation in the Central Nervous System, Heart, and Testis. Thyroid. 1998;8(10):897\u2013901. https:\/\/doi.org\/10.1089\/thy.1998.8.897.","journal-title":"Thyroid"},{"issue":"2","key":"895_CR35","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1158\/1078-0432.Ccr-20-2647","volume":"27","author":"RS Wahdan-Alaswad","year":"2021","unstructured":"Wahdan-Alaswad RS, Edgerton SM, Salem H, Kim HM, Tan AC, Finlay-Schultz J, et al. Exogenous Thyroid Hormone Is Associated with Shortened Survival and Upregulation of High-Risk Gene Expression Profiles in Steroid Receptor\u2013Positive Breast Cancers. Clin Cancer Res. 2021;27(2):585\u201397. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-20-2647.","journal-title":"Clin Cancer Res"},{"issue":"8","key":"895_CR36","doi-asserted-by":"publisher","first-page":"5000","DOI":"10.1074\/jbc.M511530200","volume":"281","author":"AA Nikrodhanond","year":"2006","unstructured":"Nikrodhanond AA, Ortiga-Carvalho TM, Shibusawa N, Hashimoto K, Liao XH, Refetoff S, et al. Dominant role of thyrotropin-releasing hormone in the hypothalamic-pituitary-thyroid axis. J Biol Chem. 2006;281(8):5000\u20137. https:\/\/doi.org\/10.1074\/jbc.M511530200.","journal-title":"J Biol Chem"},{"issue":"1\u20132","key":"895_CR37","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jsbmb.2007.12.008","volume":"109","author":"LC Hall","year":"2008","unstructured":"Hall LC, Salazar EP, Kane SR, Liu N. Effects of thyroid hormones on human breast cancer cell proliferation. J Steroid Biochem Mol Biol. 2008;109(1\u20132):57\u201366. https:\/\/doi.org\/10.1016\/j.jsbmb.2007.12.008.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"97","key":"895_CR38","doi-asserted-by":"publisher","first-page":"37069","DOI":"10.18632\/oncotarget.26434","volume":"9","author":"JT Leith","year":"2018","unstructured":"Leith JT, Mousa SA, Hercbergs A, Lin HY, Davis PJ. Radioresistance of cancer cells, integrin \u03b1v\u03b23 and thyroid hormone. Oncotarget. 2018;9(97):37069\u201375. 10.18632\/ oncotarget.26434.","journal-title":"Oncotarget"},{"issue":"1\u20132","key":"895_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mce.2008.09.022","volume":"296","author":"S Sheng","year":"2008","unstructured":"Sheng S, Barnett DH, Katzenellenbogen BS. Differential estradiol and selective estrogen receptor modulator (SERM) regulation of Keratin 13 gene expression and its underlying mechanism in breast cancer cells. Mol Cell Endocrinol. 2008;296(1\u20132):1\u20139. https:\/\/doi.org\/10.1016\/j.mce.2008.09.022.","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"895_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13058-022-01502-6","volume":"24","author":"L Yin","year":"2022","unstructured":"Yin L, Li Q, Mrdenovic S, Chu GC, Wu BJ, Bu H, et al. KRT13 promotes stemness and drives metastasis in breast cancer through a plakoglobin\/c-Myc signaling pathway. Breast Cancer Res. 2022;24(1):1\u201313. https:\/\/doi.org\/10.1186\/s13058-022-01502-6.","journal-title":"Breast Cancer Res"},{"issue":"9","key":"895_CR41","doi-asserted-by":"publisher","first-page":"10594","DOI":"10.18632\/oncotarget.7236","volume":"7","author":"H Ma","year":"2016","unstructured":"Ma H, Tian T, Liang S, Liu X, Shen H, Xia M, et al. Estrogen receptor-mediated miR-486-5p regulation of OLFM4 expression in ovarian cancer. Oncotarget. 2016;7(9):10594\u2013605. https:\/\/doi.org\/10.18632\/oncotarget.7236.","journal-title":"Oncotarget"},{"issue":"1","key":"895_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0226707","volume":"15","author":"R Ohkuma","year":"2020","unstructured":"Ohkuma R, Yada E, Ishikawa S, Komura D, Ishizaki H, Tamada K, et al. High expression of olfactomedin-4 is correlated with chemoresistance and poor prognosis in pancreatic cancer. PLoS ONE. 2020;15(1):1\u201320. https:\/\/doi.org\/10.1371\/journal.pone.0226707.","journal-title":"PLoS ONE"},{"issue":"2","key":"895_CR43","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/onc.2010.456","volume":"30","author":"V Karantza","year":"2011","unstructured":"Karantza V. Keratins in health and cancer: more than mere epithelial cell markers. Oncogene. 2011;30(2):127\u201338. https:\/\/doi.org\/10.1038\/onc.2010.456.","journal-title":"Oncogene"},{"issue":"6","key":"895_CR44","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s00418-008-0435-6","volume":"129","author":"R Moll","year":"2008","unstructured":"Moll R, Divo M, Langbein L. The human keratins: biology and pathology. Histochem Cell Biol. 2008;129(6):705\u201333. https:\/\/doi.org\/10.1007\/s00418-008-0435-6.","journal-title":"Histochem Cell Biol"},{"issue":"1","key":"895_CR45","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s10555-023-10141-y","volume":"43","author":"D Singh","year":"2024","unstructured":"Singh D, Siddique HR. Epithelial-to-mesenchymal transition in cancer progression: unraveling the immunosuppressive module driving therapy resistance. Cancer Metastasis Rev. 2024;43(1):155\u201373. https:\/\/doi.org\/10.1007\/s10555-023-10141-y.","journal-title":"Cancer Metastasis Rev"},{"issue":"7","key":"895_CR46","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1007\/s00204-021-03063-7","volume":"95","author":"J De Las Rivas","year":"2021","unstructured":"De Las Rivas J, Brozovic A, Izraely S, Casas-Pais A, Witz IP, Figueroa A. Cancer drug resistance induced by EMT: novel therapeutic strategies. Arch Toxicol. 2021;95(7):2279\u201397. https:\/\/doi.org\/10.1007\/s00204-021-03063-7.","journal-title":"Arch Toxicol"},{"issue":"2","key":"895_CR47","doi-asserted-by":"publisher","first-page":"797","DOI":"10.3892\/or.2019.7201","volume":"42","author":"SC Lim","year":"2019","unstructured":"Lim SC, Parajuli KR, Han SI. Keratin 6, induced by chronic cisplatin exposure, confers chemoresistance in human gastric carcinoma cells. Oncol Rep. 2019;42(2):797\u2013804. https:\/\/doi.org\/10.3892\/or.2019.7201.","journal-title":"Oncol Rep"},{"issue":"1","key":"895_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-022-35059-x","volume":"13","author":"A Verma","year":"2022","unstructured":"Verma A, Singh A, Singh MP, Nengroo MA, Saini KK, Satrusal SR, et al. EZH2-H3K27me3 mediated KRT14 upregulation promotes TNBC peritoneal metastasis. Nat Commun. 2022;13(1):1\u201322. https:\/\/doi.org\/10.1038\/s41467-022-35059-x.","journal-title":"Nat Commun"},{"issue":"1","key":"895_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0053532","volume":"8","author":"SV Iyer","year":"2013","unstructured":"Iyer SV, Dange PP, Alam H, Sawant SS, Ingle AD, Borges AM, et al. Understanding the Role of Keratins 8 and 18 in Neoplastic Potential of Breast Cancer Derived Cell Lines. PLoS ONE. 2013;8(1):1\u201315. https:\/\/doi.org\/10.1371\/journal.pone.0053532.","journal-title":"PLoS ONE"},{"issue":"7","key":"895_CR50","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1158\/1541-7786.Mcr-04-0117","volume":"3","author":"H B\u00fchler","year":"2005","unstructured":"B\u00fchler H, Schaller G. Transfection of Keratin 18 Gene in Human Breast Cancer Cells Causes Induction of Adhesion Proteins and Dramatic Regression of Malignancy In vitro and In vivo. Mol Cancer Res. 2005;3(7):365\u201371. https:\/\/doi.org\/10.1158\/1541-7786.Mcr-04-0117.","journal-title":"Mol Cancer Res"},{"issue":"4","key":"895_CR51","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1158\/1078-0432.Ccr-11-2100","volume":"18","author":"SA Joosse","year":"2012","unstructured":"Joosse SA, Hannemann J, Sp\u00f6tter J, Bauche A, Andreas A, M\u00fcller V, et al. Changes in Keratin Expression during Metastatic Progression of Breast Cancer: Impact on the Detection of Circulating Tumor Cells. Clin Cancer Res. 2012;18(4):993\u20131003. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-11-2100.","journal-title":"Clin Cancer Res"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-026-00895-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43440-026-00895-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-026-00895-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T07:01:56Z","timestamp":1788937316000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43440-026-00895-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,9]]},"references-count":51,"alternative-id":["895"],"URL":"https:\/\/doi.org\/10.1007\/s43440-026-00895-x","relation":{},"ISSN":["1734-1140","2299-5684"],"issn-type":[{"value":"1734-1140","type":"print"},{"value":"2299-5684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,9]]},"assertion":[{"value":"15 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"TCGA and METABRIC are publicly available datasets providing patient data with received informed consent and ethical approval. Our study used open-source data; therefore, it is exempt from ethics approval and informed consent.","order":1,"name":"Ethics","label":"<b>Ethical approval<\/b>","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"<b>Consent for publication<\/b>","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}